DR
Alpha Tau Medical Ltd
DRTS · NASDAQ
$15.24 -1.23% (-$0.19)
1M +2.14%
Market Cap $1.40B
P/E Ratio -
Div. Yield -
ROE 138.12%
Bulios Fair Price
$11.1
27.2% downside
Current Price
$15.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DRTS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 31.76x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 9.97%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 40.12%
Asset turnover 0.00x
ROE 138.12%
Debt
67 /100
Low Debt/Equity 0.34x
Int. coverage -1.16x
Current ratio 11.09x
Stability
61 /100
Moderate Beta 1.21x
Profitable years 0
EPS volatility 19.90%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DRTS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Uzi Sofer
Employees
121
Headquarters
Jerusalem
Upcoming events
19 NOV
Earnings
Upcoming earnings report